Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THRB intronic transcript 1" (THRB-IT1) appears to be a putative or uncharacterized long non-coding RNA (lncRNA) transcribed from the intronic region of the thyroid hormone receptor beta (THRB) gene. Intronic transcripts, in general, can participate in regulation of gene expression, chromatin structure, or nuclear architecture, but there is no direct evidence or scientific consensus on the specific function of THRB-IT1, its molecular mechanisms, association with disease, or druggability. There is also no supporting data identifying this entity as a receptor, enzyme, or actionable therapeutic target.
None (no established mechanism of action for drugs acting on this transcript)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THRB intronic transcript 1 (THRB-IT1).